📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
-
- EPS Growth Range (1Y):
<0%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
Current year to date yield:
2.88%
📅 SGX Earnings Announcements for UUK
Pasture Holdings Ltd. (UUK)
Market: SGX |
Currency: SGD
Address: 2 Corporation
Pasture Holdings Ltd. operates as a pharmaceutical products and medical supply company in Japan, Hong Kong, Canada, Singapore, and internationally. The company operates through three segments: Pharmaceutical Wholesale and Drop-Shipment; Masks and Medical Supplies; and Other Services. It is involved in the wholesale procurement and transshipment of pharmaceutical and nutraceutical products, such as vaccines and oncology treatments; and backend support of pharmaceutical supplies to international clients' online pharmacy businesses. The company also sells surgical masks, n95 respirators, surgical n95 respirators, and n95 respirators; wound care; urology, incontinence care, and drainage; personal protective equipment; and IV therapy and vascular access. In addition, it offers oral disintegrating strips; and pet pharmaceutical and nutraceutical products and services; and furlife, a mobile application for pets. The company was founded in 1996 and is based in Singapore. Pasture Holdings Ltd. is a subsidiary of PMI Holdings Pte. Ltd.
Show more
📈 Pasture Holdings Ltd. Historical Chart
🧾 Recent Financial Statement Analysis
November 13, 2025
Pasture Holdings Ltd. AGM 2025: Key Takeaways for Investors Pasture Holdings Ltd. Annual General Meeting 2025: Comprehensive Investor Update Overview Pasture Holdings Ltd. (SGX: [Company Registration No.: 201731601W]) held its Annual General Meeting (AGM) on 23 October 2025 at Huone…
October 21, 2025
Pasture Holdings Faces Sharp Revenue Decline, Strategic Expansion, and M&A Moves Amid Regulatory Headwinds Pasture Holdings Faces Sharp Revenue Decline, Strategic Expansion, and M&A Moves Amid Regulatory Headwinds Pasture Holdings Ltd (SGX: UUK), a Singapore-based global pharmaceuticals and medical devices…
October 18, 2025
Pasture Holdings Issues Key Corrections to Annual Report 2025: Shareholders Urged to Note Financial and Leadership Updates Pasture Holdings Issues Key Corrections to Annual Report 2025: Shareholders Urged to Note Financial and Leadership Updates Key Highlights and Investor-Relevant Corrections Pasture…
October 1, 2025
Pasture Holdings Secures Board Control with 50% Stake in AP Bioresources: A Transformative Move for Growth and Strategic Expansion Key Highlights of the Announcement Pasture Holdings Ltd (SGX: UUK) completes acquisition of a 50% equity interest in AP Bioresources Sdn…
August 26, 2025
Pasture Holdings Ltd. FY2025 Financial Results: A Detailed Analysis Pasture Holdings Ltd., a Singapore-listed healthcare and pharmaceutical company, has released its unaudited consolidated financial statements for the full year ended June 30, 2025. The results reflect both resilience and challenges…
October 14, 2024
Business OverviewCore Business Operations: Pasture Holdings Ltd. is a global pharmaceutical and medical supply company, offering products across three primary segments:Masks: Pasture Masks™, developed in collaboration with contract manufacturers, have garnered trust worldwide due to their FDA and NIOSH certifications.Medical…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: UUK, Pasture Holdings Ltd., Pasture Holdings, PASH SP, PASTURE HOLDINGS LTD, PASTURE
November 13, 2025
Pasture Holdings Ltd. AGM 2025: Key Takeaways for Investors Pasture Holdings Ltd. Annual General Meeting 2025: Comprehensive Investor Update Overview Pasture Holdings Ltd. (SGX: [Company Registration No.: 201731601W]) held its Annual General Meeting (AGM) on 23 October 2025 at Huone…
October 21, 2025
Pasture Holdings Faces Sharp Revenue Decline, Strategic Expansion, and M&A Moves Amid Regulatory Headwinds Pasture Holdings Faces Sharp Revenue Decline, Strategic Expansion, and M&A Moves Amid Regulatory Headwinds Pasture Holdings Ltd (SGX: UUK), a Singapore-based global pharmaceuticals and medical devices…
October 18, 2025
Pasture Holdings Issues Key Corrections to Annual Report 2025: Shareholders Urged to Note Financial and Leadership Updates Pasture Holdings Issues Key Corrections to Annual Report 2025: Shareholders Urged to Note Financial and Leadership Updates Key Highlights and Investor-Relevant Corrections Pasture…
October 1, 2025
Pasture Holdings Secures Board Control with 50% Stake in AP Bioresources: A Transformative Move for Growth and Strategic Expansion Key Highlights of the Announcement Pasture Holdings Ltd (SGX: UUK) completes acquisition of a 50% equity interest in AP Bioresources Sdn…
August 26, 2025
Pasture Holdings Ltd. FY2025 Financial Results: A Detailed Analysis Pasture Holdings Ltd., a Singapore-listed healthcare and pharmaceutical company, has released its unaudited consolidated financial statements for the full year ended June 30, 2025. The results reflect both resilience and challenges…
October 14, 2024
Business OverviewCore Business Operations: Pasture Holdings Ltd. is a global pharmaceutical and medical supply company, offering products across three primary segments:Masks: Pasture Masks™, developed in collaboration with contract manufacturers, have garnered trust worldwide due to their FDA and NIOSH certifications.Medical…
